SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 15th, 2024 • Alterola Biotech Inc. • Medicinal chemicals & botanical products • Delaware
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June __, 2024, is by and among Phytanix Bio, Inc., a Nevada corporation with offices located at 701 Anacapa Street, Suite C, Santa Barbara, CA 93101 (the “Company”), and each of the investors signatory hereto (individually, a “Buyer” and collectively, the “Buyers”).
Investor Rights AgreementInvestor Rights Agreement • August 15th, 2024 • Alterola Biotech Inc. • Medicinal chemicals & botanical products • New York
This Investor Rights Agreement (this “Agreement”), dated as of July 22, 2024, is among CB Holdings, Inc., a Nevada corporation (“HoldCo”), , a (the “CBRG Sponsor”), and certain shareholders of Phytanix Bio, a Nevada corporation (the “Company”) listed on Schedule A hereto (the “Company Shareholders” and, together with CBRG Sponsor, the “Holders”). Capitalized terms used but not defined herein have the meanings assigned to them in the Business Combination Agreement dated as of July 22, 2024 (as amended, supplemented, or otherwise modified from time to time in accordance with its terms, the “Business Combination Agreement”), among Chain Bridge I, a Cayman Islands exempted company (“CBRG” or the “SPAC”), the Company, HoldCo, CB Merger Sub 1, a Cayman Islands exempted company (“CBRG Merger Sub”) and CB Merger Sub 2, Inc., a Nevada corporation (“Company Merger Sub”).
BUSINESS COMBINATION AGREEMENT BY AND AMONG CHAIN BRIDGE I, CB HOLDINGS, INC., CB MERGER SUB 1 CB MERGER SUB 2, INC., AND PHYTANIX BIO DATED AS OF JULY 22, 2024Business Combination Agreement • August 15th, 2024 • Alterola Biotech Inc. • Medicinal chemicals & botanical products • New York
COMPANY SHAREHOLDER TRANSACTION SUPPORT AGREEMENTShareholder Agreement • August 15th, 2024 • Alterola Biotech Inc. • Medicinal chemicals & botanical products
This COMPANY SHAREHOLDER TRANSACTION SUPPORT AGREEMENT (this “Agreement”) is entered into as of ____________, by and among Chain Bridge I, a Cayman Islands exempted company (“CBRG”), Phytanix Bio, a Nevada corporation (the “Company”), and the party listed on the signature pages hereto as a “Shareholder” (the “Shareholder”). Each of CBRG, the Company and the Shareholder are sometimes referred to herein individually as a “Party” and collectively as the “Parties”. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Business Combination Agreement (defined below).
